glp-1 lean mass loss drugs don't steal your muscle. Weight does. A 2026 meta-analysis in Diabetes, Obesity and Metabolism compared changes between GLP-1 drugs and intensive lifestyle intervention in adults with overweight Nutritional deficiencies and muscle loss

doi:10.1186/1743-7075-7-30

AOD9604 was originally developed as an anti-obesity drug due to its lipolytic (fat burning) properties

Overall reduction in FPG is significantly higher when GLP-1RAs or dual GIPR/GLP-1R is added to basal insulin ( FPG = -14.6 mg/dL, 95% CI -21.6

But administered the blend at 2 PM after lunch

Germany Prediabetes Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Diguanide, Thiazolidinediones, Glucagon-like Peptide-1 Agonists (GLP-1), and DPP-4 Inhibitors), By Age Group (Children, Adult, and Elderly), and Germany Prediabetes Market Insights, Industry Trend, Forecasts to 2035